Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 7.25B 1.07B 933M 860M 796M 1.51B 102B 1.54B 10.3B 4.04B 49.99B 4B 3.92B 173B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 4.76B 700M 612M 564M 522M 991M 66.79B 1.01B 6.76B 2.65B 32.8B 2.63B 2.57B 114B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-0.96%
1 week+2.56%
Current month+10.70%
1 month-1.12%
3 months+1.47%
6 months-17.49%
Current year-15.98%
1 week 12.25
Extreme 12.25
12.95
1 month 11.04
Extreme 11.04
12.95
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
17.17
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 07/01/2019
Director of Finance/CFO 49 06/12/2021
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 26/03/2014
Director/Board Member 64 26/09/2017
Director/Board Member 44 26/09/2017
Date Insider Type Main position Quantity % Market Cap.
17/07/24Buy 500 0.0001%
22/01/20Sell

Director

246,300 0.0462%
01/01/20Sell 1,095,000 0.2053%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%+2.56%-21.51%-46.00% 1.07B
-0.64%-0.82%-13.70%-7.04% 12.7B
-1.20%-0.69%-35.00%-56.85% 4.67B
-0.40%-0.64%-8.24%-4.82% 4.4B
+0.55%+2.81%+23.16%-1.90% 3.92B
-1.24%-1.68%+2.64%-38.95% 3.73B
+1.30%+7.40%-7.31%-12.36% 3.27B
-0.14%+2.03%-11.48%+2.33% 3.09B
-0.89%+2.83%-5.79%-22.45% 2.42B
-0.50%+5.67%-6.00%+44.11% 1.81B
Average -0.41%+0.89%-8.32%-14.39% 4.11B
Weighted average by Cap. -0.44%+0.22%-9.26%-14.26%

Financials

2024 2025
Net sales 3.38B 497M 435M 401M 371M 704M 47.43B 716M 4.8B 1.88B 23.29B 1.87B 1.83B 80.68B 2.32B 341M 298M 275M 255M 483M 32.56B 491M 3.3B 1.29B 15.99B 1.28B 1.25B 55.38B
Net income 492M 72.41M 63.34M 58.41M 54.04M 103M 6.91B 104M 700M 274M 3.39B 272M 266M 11.76B -258M -37.94M -33.19M -30.61M -28.32M -53.75M -3.62B -54.65M -367M -144M -1.78B -142M -139M -6.16B
Net Debt -2.29B -337M -295M -272M -251M -477M -32.16B -485M -3.25B -1.28B -15.79B -1.26B -1.24B -54.7B -2.49B -367M -321M -296M -274M -520M -35B -528M -3.54B -1.39B -17.19B -1.38B -1.35B -59.54B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
09/07/26 CN¥12.41 -0.96% 5,959,081
08/07/26 CN¥12.53 +0.89% 5,369,673
07/07/26 CN¥12.42 -2.59% 5,705,226
06/07/26 CN¥12.75 +1.76% 8,482,400
03/07/26 CN¥12.53 +3.55% 7,315,100

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock